Dr. Elizabeth Brown

For the Media

Dr. Elizabeth Brown

Dr. Elizabeth Brown is a member of Fred Huthinson Cancer Research Center's Vaccine and Infectious Disease Division. Her research focus is the design and analysis of trials for HIV prevention, joint models for longitudinal and survival data and statistical methods in HIV/AIDS and cardiovascular research.  Dr. Brown leads the Microbicide Trial Network an HIV/AIDS clinical trials network established in 2006 whose work is focused on the development and rigorous evaluation of promising microbicides to prevent the sexual transmission of HIV.  

Resources for more information

  • Overview of Elizabeth Brown's Research
    Design and analysis of HIV prevention trials.
  • Elizabeth Brown – Brief Curriculum Vitae
    Appointments, affiliations and researcher interests.
  • Vaccine and Infectious Disease Division
    VIDD’s research aims at preventing, diagnosing, treating and understanding infectious diseases. There is a wide range of research topics under investigation across the fields of biology, medicine and public health. VIDD is organized into four research programs that integrate multiple research interests.
  • Microbicide Trial Network
    The MTN is an HIV/AIDS clinical trials network established in 2006 whose work is focused on the development and rigorous evaluation of promising microbicides to prevent the sexual transmission of HIV.  The MTN's Statistical and Data Management Center (MTN SDMC) is based at the SCHARP. The MTN SDMC is responsible for providing statistical leadership and facilitating all aspects of the collection, management, and analysis of data for MTN studies. 

FOR THE MEDIA

Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.


 

Photos / Graphics / Video

Download

Download photos and view video of Elizabeth Brown.

Related Stories


At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.